conv.

All stories
AIQuiet 5d · day 11

Novo Nordisk partners with Anthropic to accelerate drug discovery using Claude

The Danish drugmaker will use Claude Science and frontier models to tackle R&D challenges and compress timelines for drug development.

newest coverage 4d agosummary written 11d ago22 pieces12 likes & upvotes1 comments NewswiresBlueskyMastodonHacker NewsGoogle NewsReddit

What to know

  • Novo Nordisk will use Anthropic's Claude Science and frontier models to tackle drug discovery challenges and accelerate R&D workflows.
  • The partnership includes data governance protocols and human oversight to ensure compliance with regulatory standards.
  • Novo already uses Claude to automate trial report generation, compressing timelines from months to minutes for patient documentation.
  • The arrangement follows Novo's earlier partnerships with OpenAI and Amazon Web Services, as the company pursues multiple AI collaborations to strengthen drug development.

“By giving leading researchers access to safe, capable, and trusted frontier models, we can shorten research timelines, improve outcomes, and discover medicines and treatments that significantly improve human life.”

Dario Amodei, Anthropic CEO · Channel News Asia ↗ · Sep 15

Novo Nordisk Danish drugmakerAnthropic AI companyMike DoustdarMike Doustdar Novo CEODario AmodeiDario Amodei Anthropic CEO

Novo Nordisk partners with Anthropic to accelerate drug discovery using Claude
bsky.app

How it unfolded 2 developments, newest first · click a bar or a number to jump articlesposts

Peak 9 pieces in 3h at Sep 16, 8 AM; 22 pieces over 12 days (16 articles · 6 posts) Sep 16, 8 AM — 9 pieces · 7 articles · 2 posts — Newswires 6, Bluesky 1, Google News 1, +1 moreSep 16, 11 AM — 6 pieces · 5 articles · 1 post — Google News 4, Hacker News 1, Newswires 1Sep 16, 2 PM — 1 piece · 1 article — Newswires 1Sep 16, 5 PM — 1 piece · 1 post — Hacker News 1Sep 16, 8 PM — quietSep 16, 11 PM — quietSep 17, 2 AM — quietSep 17, 5 AM — 2 pieces · 1 article · 1 post — Mastodon 1, Newswires 1Sep 17, 8 AM — quietSep 17, 11 AM — quietSep 17, 2 PM — quietSep 17, 5 PM — 1 piece · 1 article — Newswires 1Sep 17, 8 PM — quietSep 17, 11 PM — quietSep 18, 2 AM — quietSep 18, 5 AM — 1 piece · 1 article — Newswires 1Sep 18, 8 AM — quietSep 18, 11 AM — quietSep 18, 2 PM — quietSep 18, 5 PM — quietSep 18, 8 PM — quietSep 18, 11 PM — quietSep 19, 2 AM — quietSep 19, 5 AM — quietSep 19, 8 AM — quietSep 19, 11 AM — quietSep 19, 2 PM — quietSep 19, 5 PM — quietSep 19, 8 PM — quietSep 19, 11 PM — quietSep 20, 2 AM — quietSep 20, 5 AM — quietSep 20, 8 AM — quietSep 20, 11 AM — quietSep 20, 2 PM — quietSep 20, 5 PM — quietSep 20, 8 PM — quietSep 20, 11 PM — quietSep 21, 2 AM — quietSep 21, 5 AM — quietSep 21, 8 AM — quietSep 21, 11 AM — quietSep 21, 2 PM — quietSep 21, 5 PM — quietSep 21, 8 PM — quietSep 21, 11 PM — quietSep 22, 2 AM — quietSep 22, 5 AM — quietSep 22, 8 AM — quietSep 22, 11 AM — quietSep 22, 2 PM — quietSep 22, 5 PM — quietSep 22, 8 PM — quietSep 22, 11 PM — quietSep 23, 2 AM — 1 piece · 1 post — Reddit 1Sep 23, 5 AM — quietSep 23, 8 AM — quietSep 23, 11 AM — quietSep 23, 2 PM — quietSep 23, 5 PM — quietSep 23, 8 PM — quietSep 23, 11 PM — quietSep 24, 2 AM — quietSep 24, 5 AM — quietSep 24, 8 AM — quietSep 24, 11 AM — quietSep 24, 2 PM — quietSep 24, 5 PM — quietSep 24, 8 PM — quietSep 24, 11 PM — quietSep 25, 2 AM — quietSep 25, 5 AM — quietSep 25, 8 AM — quietSep 25, 11 AM — quietSep 25, 2 PM — quietSep 25, 5 PM — quietSep 25, 8 PM — quietSep 25, 11 PM — quietYesterday, 2 AM — quietYesterday, 5 AM — quietYesterday, 8 AM — quietYesterday, 11 AM — quietYesterday, 2 PM — quietYesterday, 5 PM — quietYesterday, 8 PM — quietYesterday, 11 PM — quietToday, 2 AM — quietToday, 5 AM — quietToday, 8 AM — quietToday, 11 AM — quietToday, 2 PM — quietToday, 5 PM — quiet 1–2
Sep 17Sep 18Sep 19Sep 20Sep 21Sep 22Sep 23Sep 24Sep 25yesterdaynow · 8:27 PM ET
  1. 2

    Partnership positions Novo to accelerate drug development amid obesity market competition

    Bloomberg reports the partnership is a key strategic move as Novo tries to catch up in the competitive obesity drug market. The collaboration aims to speed up the drug development process using artificial intelligence.

    “Joining forces with Anthropic will supercharge our R&D organisation and help us on our mission to bring new, transformative health solutions to people living with chronic diseases.”
    — Mike Doustdar, Novo CEO · source

    • Novo Nordisk Taps Anthropic AI to Speed Drug Discovery https://www. bloomberg.com/news/newsletters /2026-09-17/novo-nordisk-nvo-taps-anthropic-ai-to-develop-next-generation-medicines?utm_source=flipboard&utm_medium=activitypub Posted into Bloomberg Television @ bloomberg-television-bloomberg

      bloomberg@flipboard.comMastodon10d agoview on Mastodon ↗
    1 more of the top 2 · 2 posts in this stretch
    • codename.cc

      ON THE RADAR: Novo Nordisk partners with Anthropic to accelerate drug development using AI models. Single source: Bloomberg.com. Unconfirmed. #AI #LLM

      codename.ccBluesky11d agoview on Bluesky ↗
    all of them →
  2. 1

    Novo and Anthropic announce drug discovery partnership

    Novo Nordisk and Anthropic announced a collaboration to use Claude AI models to accelerate drug discovery and development. Novo will initially test Claude Science and Anthropic's frontier models in its research and development workflows, focusing on scientific problems where their joint capabilities can have the greatest impact.

    1. 9 outlets first by Quartz, 11d ago · also BioPharma Dive, Euronews, Bloomberg Tech, Reuters, Channel News Asia, WSJ +2 · read ↗

    2. 2 outlets first by WSJ Tech, 11d ago · also Seeking Alpha · read ↗

    1 more claim →

What people are saying 0 voices from 0 sites · best of 2 · verbatim